NeuroSense Therapeutics Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q2 2024 | 2 | -$0.14 | -$0.08 | -$0.11 |
| Q3 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
NeuroSense Therapeutics Ltd. Earnings Date And Information
NeuroSense Therapeutics Ltd. last posted its earnings results on Tuesday, October 1st, 2024. The company reported $-0.02 earnings per share for the quarter, topping analysts' consensus estimates of $-0.2 by $0.18. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NeuroSense Therapeutics Ltd. has generated $-1 earnings per share over the last year ($-0.83 diluted earnings per share) and currently has a price-to-earnings ratio of -2.79. NeuroSense Therapeutics Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 27th, 2024 based on prior year's report dates.
NeuroSense Therapeutics Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q2 2024 | -$0.05 | $0 | $0 | ||
| 03/29/2024 | Q1 2024 | -$0.35 | $0 | |||
| 04/04/2024 | Q4 2023 | -$0.19 | $0 | |||
| 09/29/2023 | Q3 2023 | $0.06 | $0 | |||
| 06/30/2023 | Q2 2023 | -$0.38 | $0 | |||
| 03/31/2023 | Q1 2023 | -$0.32 | $0 | |||
| 03/22/2023 | Q4 2022 | -$0.25 | $0 | |||
| 09/30/2022 | Q3 2022 | -$0.23 | $0 | |||
| 01/19/2023 | Q2 2022 | -$0.30 | $0 | |||
| 01/19/2023 | Q1 2022 | -$0.19 | $0 | |||
| 04/14/2022 | Q4 2021 | -$0.21 | -$0.01 | 0.2 | $0 | |
| 09/30/2021 | Q3 2021 | -$0.08 | $0 | |||
| 06/30/2021 | Q2 2021 | -$0.08 | $0 | |||
| 03/31/2021 | Q1 2021 | -$0.19 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.20 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.20 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.06 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.06 | $0 |
NeuroSense Therapeutics Ltd. Earnings: Frequently Asked Questions
-
When is NeuroSense Therapeutics Ltd.'s earnings date?
NeuroSense Therapeutics Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 27th, 2024 based off last year's report dates.
-
Did NeuroSense Therapeutics Ltd. beat their earnings estimates last quarter?
In the previous quarter, NeuroSense Therapeutics Ltd. (:NRSN) reported $-0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.2 by $0.18.
-
How can I listen to NeuroSense Therapeutics Ltd.'s earnings conference call?
The conference call for NeuroSense Therapeutics Ltd.'s latest earnings report can be listened to online.
-
How can I read NeuroSense Therapeutics Ltd.'s conference call transcript?
The conference call transcript for NeuroSense Therapeutics Ltd.'s latest earnings report can be read online.
-
How much profit does NeuroSense Therapeutics Ltd. generate each year?
NeuroSense Therapeutics Ltd. (:NRSN) has a recorded net income of $0. NeuroSense Therapeutics Ltd. has generated $-0.83 earnings per share over the last four quarters.
-
What is NeuroSense Therapeutics Ltd.'s price-to-earnings ratio?
NeuroSense Therapeutics Ltd. (:NRSN) has a price-to-earnings ratio of -2.79 and price/earnings-to-growth ratio is -0.06.
